[go: up one dir, main page]

WO2008041849A3 - Procédés et moyens pour déterminer la satiété sur la salive - Google Patents

Procédés et moyens pour déterminer la satiété sur la salive Download PDF

Info

Publication number
WO2008041849A3
WO2008041849A3 PCT/NL2007/050482 NL2007050482W WO2008041849A3 WO 2008041849 A3 WO2008041849 A3 WO 2008041849A3 NL 2007050482 W NL2007050482 W NL 2007050482W WO 2008041849 A3 WO2008041849 A3 WO 2008041849A3
Authority
WO
WIPO (PCT)
Prior art keywords
biomarkers
determining
satiety
saliva
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL2007/050482
Other languages
English (en)
Other versions
WO2008041849A2 (fr
WO2008041849A8 (fr
Inventor
Leunis Forrinus Harthoorn
Raymond Godfried Schipper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STICHTING TOP-INSTITUUT VOEDSELWETENSCHAPPEN
STICHTING TOP INST VOEDSELWETE
Original Assignee
STICHTING TOP-INSTITUUT VOEDSELWETENSCHAPPEN
STICHTING TOP INST VOEDSELWETE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07115641A external-priority patent/EP2033656A1/fr
Application filed by STICHTING TOP-INSTITUUT VOEDSELWETENSCHAPPEN, STICHTING TOP INST VOEDSELWETE filed Critical STICHTING TOP-INSTITUUT VOEDSELWETENSCHAPPEN
Publication of WO2008041849A2 publication Critical patent/WO2008041849A2/fr
Publication of WO2008041849A3 publication Critical patent/WO2008041849A3/fr
Anticipated expiration legal-status Critical
Publication of WO2008041849A8 publication Critical patent/WO2008041849A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un procédé pour déterminer l'état de satiété d'un sujet mammifère comprenant l'étape de détermination dans un échantillon de salive du sujet du niveau d'un ou de plusieurs biomarqueurs. L'invention concerne également des biomarqueurs appropriés pour être utilisés dans le procédé de l'invention, en particulier dans des biomarqueurs d'hormone peptidique gastro-intestinale ou pancréatique et/ou des biomarqueurs salivaires corrélés directement à la satiété perçue dans un sujet de mammifère. L'invention propose également des supports solides comprenant un ou plusieurs anticorps spécifiques pour une hormone peptidique gastro-intestinale et/ou pancréatique et/ou des peptides salivaires appropriés pour réaliser le procédé de l'invention.
PCT/NL2007/050482 2006-10-04 2007-10-04 Procédés et moyens pour déterminer la satiété sur la salive Ceased WO2008041849A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP06121748.5 2006-10-04
EP06121748 2006-10-04
EP07100697 2007-01-17
EP07100697.7 2007-01-17
EP07115641.8 2007-09-04
EP07115641A EP2033656A1 (fr) 2007-09-04 2007-09-04 Compositions pour la modulation de la satiété par application orale

Publications (3)

Publication Number Publication Date
WO2008041849A2 WO2008041849A2 (fr) 2008-04-10
WO2008041849A3 true WO2008041849A3 (fr) 2008-10-30
WO2008041849A8 WO2008041849A8 (fr) 2009-07-23

Family

ID=39135266

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2007/050482 Ceased WO2008041849A2 (fr) 2006-10-04 2007-10-04 Procédés et moyens pour déterminer la satiété sur la salive

Country Status (1)

Country Link
WO (1) WO2008041849A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5822822B2 (ja) 2009-04-17 2015-11-24 ニューヨーク ユニバーシティ Ｔｎｆファミリー受容体を標的とし、ｔｎｆ作用を拮抗するペプチド、その組成物、方法および使用
WO2015073878A1 (fr) * 2013-11-15 2015-05-21 Ur Diet, Llc Rétroaction biologique de la satiété en temps réel
WO2019209897A1 (fr) * 2018-04-27 2019-10-31 Marashi Amir Procédés de détermination du remplissage de l'estomac et procédés associés de sécurité médicale

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AALTO YAN ET AL: "Does bombesin-like peptide mediate radiation-induced anorexia and satiety?", ACTA ONCOLOGICA (STOCKHOLM), vol. 38, no. 8, 1999, pages 1099 - 1102, XP002476673, ISSN: 0284-186X *
AYDIN S ET AL: "A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects", PEPTIDES, ELSEVIER, AMSTERDAM, US, vol. 26, no. 4, April 2005 (2005-04-01), pages 647 - 652, XP004773455, ISSN: 0196-9781 *
DATABASE UniProt [online] 1 January 1998 (1998-01-01), "FMRFamide-related peptides precursor [Contains: Neuropeptide SF (NPSF); Neuropeptide FF (NPFF); Neuropeptide AF (NPAF)].", XP002476676, retrieved from EBI accession no. UNIPROT:O15130 Database accession no. O15130 *
DOCKRAY GRAHAM J: "The expanding family of -RFamide peptides and their effects on feeding behaviour", EXPERIMENTAL PHYSIOLOGY, vol. 89, no. 3, May 2004 (2004-05-01), pages 229 - 235, XP002476675, ISSN: 0958-0670 *
SUNTER DAVID ET AL: "Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat", NEUROSCIENCE LETTERS, vol. 313, no. 3, 9 November 2001 (2001-11-09), pages 145 - 148, XP002476674, ISSN: 0304-3940 *

Also Published As

Publication number Publication date
WO2008041849A2 (fr) 2008-04-10
WO2008041849A8 (fr) 2009-07-23

Similar Documents

Publication Publication Date Title
WO2008048970A3 (fr) Anticorps synthétiques
WO2007089303A3 (fr) Méthodes et compositions de diagnostic de la spondylarthrite ankylosante à l'aide de biomarqueurs
EP1814586A4 (fr) Anticorps anti-properdine et procede de fabrication et d'utilisation de ceux-ci
WO2010065568A3 (fr) Procédés et dosages pour mesurer p95 et/ou p95 dans un échantillon et anticorps spécifiques de p95
EP1894359A4 (fr) Méthode et disposition pour la détermination de coûts de route et sélection avec interaction des coûts de route
WO2009140039A3 (fr) Anticorps synthétiques
WO2007146385A3 (fr) Complexe protéine/peptide lié à l'albumine en tant que biomarqueur pour une maladie
WO2008060483A3 (fr) Biocapteurs d'interaction protéine-protéine et leurs procédés d'utilisation
ZA200711153B (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
WO2009143098A3 (fr) Auto-anticorps humains isolés dirigés contre des peptides natriurétiques et procédés et kits pour détecter des auto-anticorps humains dirigés contre des peptides natriurétiques
WO2008073425A3 (fr) Dosage grande sensibilité de la protéolyse
WO2011053565A3 (fr) Compositions et méthodes de détection d'une tauopathie
WO2008102340A3 (fr) Trousses et procédés de détermination de la propreté du colon
WO2007092173A3 (fr) Analyses des bandes de flux lateral par spectroscopie de raman
WO2006069023A3 (fr) Procede et appareil d'analyse avec effets de matrices d'echantillons reduits
DE60320207D1 (de) N- oder C-terminale Peptid-Auswahlmethode für Proteomics
WO2010009074A3 (fr) Procédé de prédiction et de détection de métastases tumorales
WO2006088700A3 (fr) Anticorps se liant au peptide bnp humain specifique du noyau
WO2008041849A3 (fr) Procédés et moyens pour déterminer la satiété sur la salive
IL177239A0 (en) Monoclonal antibody based biomarker discovery and development platform
WO2006076687A3 (fr) Dosages elisa utilisant des reactifs peptides specifiques du prion
WO2007048084A3 (fr) Analyse judiciaire de salive humaine
WO2006091421A3 (fr) Peptides pour la detection d'un anticorps dirige contre ehrlichia ewingii
ITMI20040858A1 (it) Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
WO2008047086A3 (fr) Biomarqueur

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07834620

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07834620

Country of ref document: EP

Kind code of ref document: A2